Literature DB >> 26719649

Cutaneous and Systemic Plasmacytosis Associated with Renal Amyloidosis.

Taek Geun Lee1, Woo Seok Jeong1, Seung Hyun Moon1, Hyun Hwangbo1, Sook Kyung Lee1, Dong Ryeol Lee2, Tae Gwang Kwon3.   

Abstract

Cutaneous and systemic plasmacytosis (CSP) is a rare disorder of unknown etiology characterized by cutaneous polyclonal plasma cell infiltrates associated with various extracutaneous involvement and polyclonal hypergammaglobulinemia. Here, we report on a 54-year-old male patient with chronic renal insufficiency who presented with disseminated reddish-brown macules and plaques on the face and trunk. In our evaluation, he was found to have lymphadenopathy, polyclonal hypergammaglobulinemia; benign plasma cell infiltration involving the skin, bone marrow, and retroperitoneal area; and renal amyloidosis. To the best of our knowledge, this is the first reported case of CSP associated with renal amyloidosis.

Entities:  

Keywords:  Cutaneous and systemic plasmacytosis; Renal amyloidosis

Year:  2015        PMID: 26719649      PMCID: PMC4695432          DOI: 10.5021/ad.2015.27.6.759

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  10 in total

1.  Plasmacytosis: systemic or cutaneous, are they distinct?

Authors:  Y Tada; M Komine; S Suzuki; K Kikuchi; M Sasaki; N Kaneko; K Tamaki
Journal:  Acta Derm Venereol       Date:  2000-05       Impact factor: 4.437

2.  Extensive hyperpigmented plaques in a chinese singaporean woman: a case of cutaneous plasmacytosis.

Authors:  Joyce Ss Lee; Lynn Chiam; Kong Bing Tan; Manuel Salto-Tellez; Suat Hoon Tan; Beng Hock Ong; See Ket Ng
Journal:  Am J Dermatopathol       Date:  2011-07       Impact factor: 1.533

3.  A case of plasmacytosis with multiple peculiar eruptions.

Authors:  K Kitamura; N Tamura; H Hatano; K Toyama; A Mikata; S Watanabe
Journal:  J Dermatol       Date:  1980-10       Impact factor: 4.005

4.  Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: significant serum interleukin-6 levels.

Authors:  A Kodama; M Tani; K Hori; T Tozuka; T Matsui; M Ito; S Nakao; T Fujita; H Kobayashi
Journal:  Br J Dermatol       Date:  1992-07       Impact factor: 9.302

5.  Report on 59 patients with renal amyloidosis.

Authors:  S Paydas
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

6.  Increased plasma interleukin-6 in cutaneous plasmacytoma: the effect of intralesional steroid therapy.

Authors:  T Yamamoto; I Katayama; K Nishioka
Journal:  Br J Dermatol       Date:  1997-10       Impact factor: 9.302

7.  Cutaneous and systemic plasmacytosis showing histopathologic features as mixed-type Castleman disease: a case report.

Authors:  Hao Chen; Yanning Xue; Yiqun Jiang; Xuesi Zeng; Jian-fang Sun
Journal:  Am J Dermatopathol       Date:  2012-07       Impact factor: 1.533

8.  Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States.

Authors:  Hesham M Amin; Peter McLaughlin; Cynthia J Rutherford; Lynne V Abruzzo; Dan Jones
Journal:  Am J Dermatopathol       Date:  2002-06       Impact factor: 1.533

9.  Cutaneous and systemic plasmacytosis: a Chinese case.

Authors:  Hui-Jun Ma; Wen Liu; You Li; Guang Zhao; Ru-Song Meng; Dong-Guang Li
Journal:  J Dermatol       Date:  2008-08       Impact factor: 4.005

10.  Cutaneous plasmacytosis: report of 6 cases with or without systemic involvement.

Authors:  Rie Honda; Lorenzo Cerroni; Akiko Tanikawa; Tamotsu Ebihara; Masayuki Amagai; Akira Ishiko
Journal:  J Am Acad Dermatol       Date:  2013-01-27       Impact factor: 11.527

  10 in total
  2 in total

1.  A Rare Case of Cutaneous Plasmacytosis in a Korean Male.

Authors:  Corey Georgesen; Meenal Kheterpal; Melissa Pulitzer
Journal:  Case Rep Pathol       Date:  2017-08-07

Review 2.  Plasma Cell Leukemia: Definition, Presentation, and Treatment.

Authors:  Michael Tveden Gundesen; Thomas Lund; Hanne E H Moeller; Niels Abildgaard
Journal:  Curr Oncol Rep       Date:  2019-01-28       Impact factor: 5.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.